Sycomore Social Impact

Sycomore Social Impact overweights companies that offer solutions to the major global societal challenges and integrate this quest for a positive impact into their strategy, in order to deliver profitable and sustainable growth. The fund aims to outperform the Euro Stoxx Total Return through a socially responsible investment process. The investment universe consists of all listed stocks in continental Europe with no company size constraints.

Markets continued to rally in November, lifted by resilient corporate earnings and hopes that the Fed may slow the pace of its interest rate hikes. In this newly “risk-on” environment, the fund suffered from its overexposure to healthcare, which benefited less than other sectors from the market rally. Rovi, the Spanish pharmaceuticals player, featured among leading negative contributors due to the slowdown of Covid vaccines and delays in the approval of two of its most promising treatments by the FDA. We feel the market over-reacted to this news and chose to strengthen our position. In contrast, Alstom rebounded sharply on the back of reassuring reports on cashflow generation and the impacts of inflation. Small and mid-caps, notably within the tech sector – such as Esker, Believe, Cancom, Compugroup or Tinexta, benefited from investors swith to a more “risk-on” positioning.

We would like to draw investors’ attention to the fact that the information available on this website is of a general nature and should not be construed as either adapted to the specific needs or circumstances of a given investor, nor as providing personal investment recommendations or financial advice.

The information available on this website is provided for information purposes only. SYCOMORE ASSET MANAGEMENT cannot be held liable for an investment or divestment decision made solely on the basis of the information provided herein. Although we believe the information made available on this website to be reliable, it should not be assumed to be exhaustive. SYCOMORE AM reserves the right to amend the contents on a discretionary basis and with no prior notice. If, despite the attention paid by SYCOMORE AM to the quality and timeliness of the information published on this website, some of the information is proved to be wrong or incomplete, SYCOMORE AM shall correct the situation as soon as possible but cannot be held liable for any errors, omissions or flaws that may be noted. Where necessary, you may report any flaws you have noted at the following address: info@sycomore-am.com.

We would like to remind investors that past performance is no guide to future returns and is not consistent over time. Our funds offer no yield or performance guarantees and carry a risk of capital loss. Before investing, please read the fund’s KIID available on our website www.sycomore-am.com or upon simple request from SYCOMORE ASSET MANAGEMENT. Our funds are offered to all investors and may be used in unit-based life-assurance contracts. The minimum investment horizon of each fund is indicated in its prospectus. The amount that is reasonable to invest in our funds will depend upon your personal situation. This can be determined by considering your personal wealth, current and future needs, and whether you are prepared to take on risks or prefer a cautious investment. We also highly recommend that you diversify your investments sufficiently to avoid exposing your capital exclusively to the risks associated with our funds.

The funds presented below are domiciled in France or in Luxembourg and may not be authorized for sale in your country. Each fund factsheet provides information on the countries in which the fund is registered. Units of our FCPs – which are Foreign Public Funds as per section 13 of the US Bank Holding Company Act – have not been registered or declared to the US authorities as per the US Securities Act of 1933. As a result, they may not be offered or sold, either directly or indirectly, in the United States or on behalf of a “US Person” as defined by the US regulation (Regulation S). In all circumstances, the user of the present site is responsible for ensuring beforehand that his or her connection to this website and access to the information contained herein is neither a failure to meet regulatory obligations, nor a regulatory violation on account of his or her own legal situation, particularly with respect to the national law applicable to the individual.

Track record

Giulia Culot

Luca Fasan

Catherine Rolland

Performance as of 12.19.2024

Characteristics

Classification

Subscriptions & redemptions

Management fees

Risk indicator

Looking to invest?

Find out more

Contact us

Non-liability clause